Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone and oxygen support strategies in ICU patients with Covid-19 pneumonia
2020-001457-43Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexamethasone in coronavirus pneumonia and Acute hypoxaemic respiratory failure (AHRF) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Time to death from all causes within 60 days and Time to need for mechanical ventilation. Started Apr 2020; status: active.
02
Drugs
dexamethasone
03
Conditions
coronavirus pneumoniaAcute hypoxaemic respiratory failure (AHRF)
Beyond the preview
Go deeper on 2020-001457-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001457-43.